# Sunhydrogen, Inc.: financial statements, quarterly

HYSR · OTC · CIK 1481028 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/hysr.md) · [Financials](/companies/hysr/financials.md) · [Filings](/companies/hysr/filings.md) · [Insiders](/companies/hysr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hysr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.3](/filings/0001213900-25-108125.md) | [0.0 d](/filings/0001213900-26-015703.md) | [0.0 d](/filings/0001213900-26-053947.md) | [0.0 d](/filings/0001213900-26-103598.md) |
| Research and development | $k | [439](/filings/0001213900-24-096976.md) | [756](/filings/0001213900-25-011506.md) | [751](/filings/0001213900-25-041497.md) | [623 d](/filings/0001213900-25-087311.md) | [608](/filings/0001213900-25-108125.md) | [626](/filings/0001213900-26-015703.md) | [1,135](/filings/0001213900-26-053947.md) | [1,071 d](/filings/0001213900-26-103598.md) | [1,199](/filings/0001213900-25-108125.md) | [969](/filings/0001213900-26-015703.md) | [943](/filings/0001213900-26-053947.md) | [1,223 d](/filings/0001213900-26-103598.md) |
| Operating income | $k | [(999)](/filings/0001213900-24-096976.md) | [(1,265)](/filings/0001213900-25-011506.md) | [(1,832)](/filings/0001213900-25-041497.md) | [(906) d](/filings/0001213900-25-087311.md) | [(1,036)](/filings/0001213900-25-108125.md) | [(1,258)](/filings/0001213900-26-015703.md) | [(2,138)](/filings/0001213900-26-053947.md) | [(1,384) d](/filings/0001213900-26-103598.md) | [(1,923)](/filings/0001213900-25-108125.md) | [(1,669)](/filings/0001213900-26-015703.md) | [(1,729)](/filings/0001213900-26-053947.md) | [(2,200) d](/filings/0001213900-26-103598.md) |
| Interest expense | $k | [1.7](/filings/0001213900-23-086013.md) | [1.7](/filings/0001213900-24-013335.md) | [1.7](/filings/0001213900-24-045549.md) | [(0.5) d](/filings/0001213900-25-087311.md) | [0.5](/filings/0001213900-25-108125.md) | [0.1](/filings/0001213900-26-015703.md) | [0.0 d](/filings/0001213900-26-053947.md) | [0.0 d](/filings/0001213900-26-103598.md) | not reported | not reported | not reported | not reported |
| Net income | $k | [(448)](/filings/0001213900-25-041497.md) | [(3,029)](/filings/0001213900-25-041497.md) | [(4,022)](/filings/0001213900-25-041497.md) | [(2,382) d](/filings/0001213900-25-087311.md) | [(2,047)](/filings/0001213900-26-053947.md) | [(3,471)](/filings/0001213900-26-053947.md) | [(1,738)](/filings/0001213900-26-053947.md) | [(970) d](/filings/0001213900-26-103598.md) | [(1,560)](/filings/0001213900-26-053947.md) | [(1,498)](/filings/0001213900-26-053947.md) | [(1,534)](/filings/0001213900-26-053947.md) | [(1,939) d](/filings/0001213900-26-103598.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001213900-24-096976.md) | [0.00](/filings/0001213900-25-011506.md) | [0.00](/filings/0001213900-25-041497.md) | not reported | [0.00](/filings/0001213900-25-108125.md) | [0.00](/filings/0001213900-26-015703.md) | [0.00](/filings/0001213900-26-053947.md) | not reported | [0.00](/filings/0001213900-25-108125.md) | [0.00](/filings/0001213900-26-015703.md) | [0.00](/filings/0001213900-26-053947.md) | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001213900-24-096976.md) | [0.00](/filings/0001213900-25-011506.md) | [0.00](/filings/0001213900-25-041497.md) | not reported | [0.00](/filings/0001213900-25-108125.md) | [0.00](/filings/0001213900-26-015703.md) | [0.00](/filings/0001213900-26-053947.md) | not reported | [0.00](/filings/0001213900-25-108125.md) | [0.00](/filings/0001213900-26-015703.md) | [0.00](/filings/0001213900-26-053947.md) | not reported |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [34.9](/filings/0001213900-23-086013.md) | [34.7](/filings/0001213900-24-013335.md) | [39.2](/filings/0001213900-24-045549.md) | [39.0](/filings/0001213900-25-087311.md) | [40.5](/filings/0001213900-24-096976.md) | [39.6](/filings/0001213900-25-011506.md) | [32.2](/filings/0001213900-25-041497.md) | [34.6](/filings/0001213900-26-103598.md) | [33.5](/filings/0001213900-25-108125.md) | [14.4](/filings/0001213900-26-015703.md) | [13.1](/filings/0001213900-26-053947.md) | [12.1](/filings/0001213900-26-103598.md) |
| Current assets | $m | [47.9](/filings/0001213900-23-086013.md) | [45.5](/filings/0001213900-24-013335.md) | [42.2](/filings/0001213900-24-045549.md) | [43.1](/filings/0001213900-25-087311.md) | [43.1](/filings/0001213900-24-096976.md) | [39.8](/filings/0001213900-25-011506.md) | [38.4](/filings/0001213900-25-041497.md) | [37.7](/filings/0001213900-26-103598.md) | [35.5](/filings/0001213900-25-108125.md) | [34.3](/filings/0001213900-26-015703.md) | [33.8](/filings/0001213900-26-053947.md) | [32.7](/filings/0001213900-26-103598.md) |
| Total assets | $m | [51.0](/filings/0001213900-23-086013.md) | [48.7](/filings/0001213900-24-013335.md) | [45.4](/filings/0001213900-24-045549.md) | [43.4](/filings/0001213900-25-087311.md) | [43.4](/filings/0001213900-24-096976.md) | [40.0](/filings/0001213900-25-011506.md) | [38.6](/filings/0001213900-25-041497.md) | [37.9](/filings/0001213900-26-103598.md) | [35.7](/filings/0001213900-25-108125.md) | [34.5](/filings/0001213900-26-015703.md) | [33.9](/filings/0001213900-26-053947.md) | [32.9](/filings/0001213900-26-103598.md) |
| Current liabilities | $m | [0.3](/filings/0001213900-23-086013.md) | [0.6](/filings/0001213900-24-013335.md) | [0.5](/filings/0001213900-24-045549.md) | [0.8](/filings/0001213900-24-083387.md) | not reported | not reported | not reported | [0.7](/filings/0001213900-26-103598.md) | not reported | not reported | not reported | [0.9](/filings/0001213900-26-103598.md) |
| Total liabilities | $m | [0.3](/filings/0001213900-23-086013.md) | [0.6](/filings/0001213900-24-013335.md) | [0.5](/filings/0001213900-24-045549.md) | [0.8](/filings/0001213900-25-087311.md) | [0.6](/filings/0001213900-24-096976.md) | [0.5](/filings/0001213900-25-011506.md) | [0.4](/filings/0001213900-25-041497.md) | [0.7](/filings/0001213900-26-103598.md) | [0.8](/filings/0001213900-25-108125.md) | [0.7](/filings/0001213900-26-015703.md) | [0.7](/filings/0001213900-26-053947.md) | [0.9](/filings/0001213900-26-103598.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [49.8](/filings/0001213900-25-041497.md) | [47.2](/filings/0001213900-25-041497.md) | [44.0](/filings/0001213900-25-041497.md) | [41.7](/filings/0001213900-26-103598.md) | [41.9](/filings/0001213900-26-053947.md) | [38.8](/filings/0001213900-26-053947.md) | [37.5](/filings/0001213900-26-053947.md) | [36.6](/filings/0001213900-26-103598.md) | [34.5](/filings/0001213900-26-053947.md) | [33.2](/filings/0001213900-26-053947.md) | [32.9](/filings/0001213900-26-053947.md) | [31.8](/filings/0001213900-26-103598.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(475)](/filings/0001213900-24-096976.md) | [(474) d](/filings/0001213900-25-011506.md) | [(822) d](/filings/0001213900-25-041497.md) | [(72.1) d](/filings/0001213900-25-087311.md) | [(704)](/filings/0001213900-25-108125.md) | [(865) d](/filings/0001213900-26-015703.md) | [(1,402) d](/filings/0001213900-26-053947.md) | [(676) d](/filings/0001213900-26-103598.md) | [(1,186)](/filings/0001213900-25-108125.md) | [(1,110) d](/filings/0001213900-26-015703.md) | [(1,555) d](/filings/0001213900-26-053947.md) | [(1,213) d](/filings/0001213900-26-103598.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4,272](/filings/0001213900-23-086013.md) | [5,385](/filings/0001213900-24-013335.md) | [5,537](/filings/0001213900-24-045549.md) | [4,862](/filings/0001213900-24-096976.md) | [5,070](/filings/0001213900-25-011506.md) | [5,094](/filings/0001213900-25-041497.md) | [5,102](/filings/0001213900-25-108125.md) | [5,304](/filings/0001213900-26-015703.md) | [5,437](/filings/0001213900-26-053947.md) | [5,438](/filings/0001213900-25-108125.md) | [5,438](/filings/0001213900-26-015703.md) | [5,520](/filings/0001213900-26-053947.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,749,164,916 at 2026-09-25, from the cover of the [10-K filed 2026-09-25](/filings/0001213900-26-103598.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.